It was a busy week in the biotech sector, with many regulatory and pipeline updates. Neumora Therapeutics NMRA plummeted on ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

US-based Lantheus Holdings becomes largest shareholder in Radiopharm Theranostics after US$5 million private placement.

The Genome India Project marks a defining moment in the country’s biotechnology landscape, My best wishes to those associated ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing ...

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pioneering a Sustainable Future is a mini-documentary highlighting Flagship Pioneering’s contributions to climate change solutions and food security.